EGFR and glioblastoma: Thus, the presence of any of the following five criteria is sufficient to designate an IDH-wildtype diffuse astrocytic glioma as glioblastoma: microvascular proliferation, necrosis, TERT promotor mutation, EGFR gene amplification, or 17/–10 chromosome copy number changes [2].